Neumora Therapeutics

Develops precision medicines for neuropsychiatric and neurodegenerative brain diseases

Founded 2019 · 95 employees · United States · Public

Listed:

NASDAQ: NMRA

Subsidiaries:

Abelian Therapeutics, BlackThorn Therapeutics, Syllable Life Sciences, Propellex Bio, Alairion